K. Faraguna

发表

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses.

E. Gehan, J. Marshall, J. Schlom, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.